Reimbursement Briefs: PillCam Reimbursement In Japan; 3-D Mammo Code Withdrawn; CMS Data Sharing

Japan will reimburse PillCam COLON. 3-D mammography CPT code application withdrawn from AMA CPT Editorial Panel meeting. CMS unveils new virtual research data-sharing tool.

Given Imaging Ltd. announced Nov. 11 that Japan’s Central Social Insurance Medical Council, Chuikyo, has approved its PillCam COLON for reimbursement, based on a recommendation by the Japanese Ministry of Health, Labor and Welfare. As of Jan. 1, each PillCam COLON capsule will be reimbursed in Japan for 83,100 yen, or approximately $840.00. In December, the Japanese MHLW will determine the final indication for use for PillCam COLON, an ingestible capsule that provides images of the colon, as well as the amount for the professional fee. Japan’s Pharmaceuticals & Medical Devices Agency granted regulatory clearance for PillCam COLON in July.

PillCam COLON received a CE mark in 2006 and is available in Europe, Israel, Asia, Latin America, Canada and Australia....

More from Policy & Regulation

More from Medtech Insight

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device

 

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Execs On The Move: June 23–27, 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Court Orders US FDA To Return Trial Diversity Action Plan Guidance To Website

 
• By 

HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.